New-onset gastrointestinal disorders in COVID-19 patients 3.5 years post-infection in the inner-city population in the Bronx

Abstract This study examined the incidence, characteristics, and risk factors of new gastrointestinal disorders (GID) associated with SARS-CoV-2 infection up to 3.5 years post-infection. This retrospective study included 35,102 COVID-19 patients and 682,594 contemporary non-COVID-19 patients without...

Full description

Saved in:
Bibliographic Details
Main Authors: Sagar Changela, Samad Ashraf, Justin Y. Lu, Kevin E. Duong, Sonya Henry, Stephen H. Wang, Tim Q. Duong
Format: Article
Language:English
Published: Nature Portfolio 2024-12-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-83232-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559511595220992
author Sagar Changela
Samad Ashraf
Justin Y. Lu
Kevin E. Duong
Sonya Henry
Stephen H. Wang
Tim Q. Duong
author_facet Sagar Changela
Samad Ashraf
Justin Y. Lu
Kevin E. Duong
Sonya Henry
Stephen H. Wang
Tim Q. Duong
author_sort Sagar Changela
collection DOAJ
description Abstract This study examined the incidence, characteristics, and risk factors of new gastrointestinal disorders (GID) associated with SARS-CoV-2 infection up to 3.5 years post-infection. This retrospective study included 35,102 COVID-19 patients and 682,594 contemporary non-COVID-19 patients without past medical history of GID (controls) from the Montefiore Health System in the Bronx (3/1/2020 to 7/31/2023). Comparisons were made with unmatched and propensity-matched (1:2) controls. The primary outcome was new GID which included peptic ulcer, inflammatory bowel disease, irritable bowel syndrome, diverticulosis, diverticulitis, and biliary disease. Multivariate Cox proportional hazards model analysis was performed with adjustment for covariates. There were 2,228 (6.34%) COVID-19 positive patients who developed new GID compared to 38,928 (5.70%) controls. COVID-19 patients had an elevated risk of developing new GID (adjusted HR = 1.18 (95% CI 1.12–1.25) compared to propensity-matched controls, after adjusting for confounders that included smoking, obesity, diabetes, hypertension. These findings underscore the need for additional research and follow-up of at-risk individuals for developing GID post infection.
format Article
id doaj-art-a933ad4dfda64302ad26c3f9fa078ab7
institution Kabale University
issn 2045-2322
language English
publishDate 2024-12-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-a933ad4dfda64302ad26c3f9fa078ab72025-01-05T12:26:23ZengNature PortfolioScientific Reports2045-23222024-12-011411910.1038/s41598-024-83232-7New-onset gastrointestinal disorders in COVID-19 patients 3.5 years post-infection in the inner-city population in the BronxSagar Changela0Samad Ashraf1Justin Y. Lu2Kevin E. Duong3Sonya Henry4Stephen H. Wang5Tim Q. Duong6Department of Radiology, Albert Einstein College of Medicine and Montefiore Medical CenterDepartment of Radiology, Albert Einstein College of Medicine and Montefiore Medical CenterDepartment of Radiology, Albert Einstein College of Medicine and Montefiore Medical CenterDepartment of Radiology, Albert Einstein College of Medicine and Montefiore Medical CenterDepartment of Radiology, Albert Einstein College of Medicine and Montefiore Medical CenterDepartment of Radiology, Albert Einstein College of Medicine and Montefiore Medical CenterDepartment of Radiology, Albert Einstein College of Medicine and Montefiore Medical CenterAbstract This study examined the incidence, characteristics, and risk factors of new gastrointestinal disorders (GID) associated with SARS-CoV-2 infection up to 3.5 years post-infection. This retrospective study included 35,102 COVID-19 patients and 682,594 contemporary non-COVID-19 patients without past medical history of GID (controls) from the Montefiore Health System in the Bronx (3/1/2020 to 7/31/2023). Comparisons were made with unmatched and propensity-matched (1:2) controls. The primary outcome was new GID which included peptic ulcer, inflammatory bowel disease, irritable bowel syndrome, diverticulosis, diverticulitis, and biliary disease. Multivariate Cox proportional hazards model analysis was performed with adjustment for covariates. There were 2,228 (6.34%) COVID-19 positive patients who developed new GID compared to 38,928 (5.70%) controls. COVID-19 patients had an elevated risk of developing new GID (adjusted HR = 1.18 (95% CI 1.12–1.25) compared to propensity-matched controls, after adjusting for confounders that included smoking, obesity, diabetes, hypertension. These findings underscore the need for additional research and follow-up of at-risk individuals for developing GID post infection.https://doi.org/10.1038/s41598-024-83232-7long covidpost-acute sequelae of COVID-19 (PASC)health disparitySARS-CoV-2
spellingShingle Sagar Changela
Samad Ashraf
Justin Y. Lu
Kevin E. Duong
Sonya Henry
Stephen H. Wang
Tim Q. Duong
New-onset gastrointestinal disorders in COVID-19 patients 3.5 years post-infection in the inner-city population in the Bronx
Scientific Reports
long covid
post-acute sequelae of COVID-19 (PASC)
health disparity
SARS-CoV-2
title New-onset gastrointestinal disorders in COVID-19 patients 3.5 years post-infection in the inner-city population in the Bronx
title_full New-onset gastrointestinal disorders in COVID-19 patients 3.5 years post-infection in the inner-city population in the Bronx
title_fullStr New-onset gastrointestinal disorders in COVID-19 patients 3.5 years post-infection in the inner-city population in the Bronx
title_full_unstemmed New-onset gastrointestinal disorders in COVID-19 patients 3.5 years post-infection in the inner-city population in the Bronx
title_short New-onset gastrointestinal disorders in COVID-19 patients 3.5 years post-infection in the inner-city population in the Bronx
title_sort new onset gastrointestinal disorders in covid 19 patients 3 5 years post infection in the inner city population in the bronx
topic long covid
post-acute sequelae of COVID-19 (PASC)
health disparity
SARS-CoV-2
url https://doi.org/10.1038/s41598-024-83232-7
work_keys_str_mv AT sagarchangela newonsetgastrointestinaldisordersincovid19patients35yearspostinfectionintheinnercitypopulationinthebronx
AT samadashraf newonsetgastrointestinaldisordersincovid19patients35yearspostinfectionintheinnercitypopulationinthebronx
AT justinylu newonsetgastrointestinaldisordersincovid19patients35yearspostinfectionintheinnercitypopulationinthebronx
AT kevineduong newonsetgastrointestinaldisordersincovid19patients35yearspostinfectionintheinnercitypopulationinthebronx
AT sonyahenry newonsetgastrointestinaldisordersincovid19patients35yearspostinfectionintheinnercitypopulationinthebronx
AT stephenhwang newonsetgastrointestinaldisordersincovid19patients35yearspostinfectionintheinnercitypopulationinthebronx
AT timqduong newonsetgastrointestinaldisordersincovid19patients35yearspostinfectionintheinnercitypopulationinthebronx